Jason K. Garland's most recent trade in Repligen Corp. was a trade of 6,435 Common Stock done . Disclosure was reported to the exchange on March 3, 2025.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Repligen Corp. | Jason K. Garland | CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Mar 2025 | 6,435 | 13,795 (0%) | 0% | 0 | Common Stock | |
Repligen Corp. | Jason K. Garland | CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Mar 2025 | 6,056 | 6,056 | - | - | Stock Option (Right to Buy) | |
Repligen Corp. | Jason K. Garland | CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 156.54 per share. | 27 Feb 2025 | 316 | 7,360 (0%) | 0% | 156.5 | 49,467 | Common Stock |
Repligen Corp. | Jason K. Garland | CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 123.41 per share. | 20 Nov 2024 | 367 | 7,676 (0%) | 0% | 123.4 | 45,291 | Common Stock |
Repligen Corp. | Garland K. Jason | CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Feb 2024 | 2,540 | 8,043 (0%) | 0% | 0 | Common Stock | |
Repligen Corp. | Jason K. Garland | CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Feb 2024 | 2,523 | 2,523 | - | - | Stock Option (Right to Buy) | |
Acutus Medical Inc | Jason K. Garland | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2023 | 19,600 | 19,600 | - | - | FORM 4 | |
Acutus Medical Inc | Jason K. Garland | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2023 | 8,400 | 22,400 | - | 0 | FORM 4 | |
Integer Holdings Corp | Jason K. Garland | EVP, Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jan 2023 | 6,849 | 6,849 | - | - | Restricted Stock Units | |
Integer Holdings Corp | Jason K. Garland | EVP, Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jan 2023 | 2,633 | 14,202 (0%) | 0% | - | Common Stock | |
Integer Holdings Corp | Jason K. Garland | EVP, Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Jan 2023 | 1,901 | 3,803 | - | - | Restricted Stock Units | |
Integer Holdings Corp | Jason K. Garland | EVP, Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Jan 2023 | 1,901 | 16,103 (0%) | 0% | - | Common Stock | |
Integer Holdings Corp | Jason K. Garland | EVP, Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 74.21 per share. | 20 Jan 2023 | 1,572 | 16,061 (0%) | 0% | 74.2 | 116,658 | Common Stock |
Integer Holdings Corp | Jason K. Garland | EVP, Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Jan 2023 | 1,530 | 1,531 | - | - | Restricted Stock Units | |
Integer Holdings Corp | Jason K. Garland | EVP, Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Jan 2023 | 1,530 | 17,633 (0%) | 0% | - | Common Stock | |
Integer Holdings Corp | Jason K. Garland | EVP, Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Dec 2022 | 1,205 | 11,863 (0%) | 0% | - | Common Stock | |
Integer Holdings Corp | Jason K. Garland | EVP, Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Dec 2022 | 1,205 | 0 | - | - | Restricted Stock Units | |
Integer Holdings Corp | Jason K. Garland | EVP, Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 68.46 per share. | 31 Dec 2022 | 294 | 11,569 (0%) | 0% | 68.5 | 20,127 | Common Stock |
Integer Holdings Corp | Jason K. Garland | EVP, Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Nov 2022 | 16,077 | 16,077 | - | - | Restricted Stock Units | |
Acutus Medical Inc | Jason K. Garland | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Sep 2022 | 32,500 | 32,500 | - | - | Stock Options (Right to Buy) | |
Acutus Medical Inc | Jason K. Garland | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Sep 2022 | 14,000 | 14,000 | - | 0 | Common Stock | |
Integer Holdings Corp | Jason K. Garland | EVP, Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Jan 2022 | 5,704 | 5,704 | - | - | Restricted Stock Units | |
Integer Holdings Corp | Jason K. Garland | EVP, Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Jan 2022 | 1,530 | 3,061 | - | - | Restricted Stock Units | |
Integer Holdings Corp | Jason K. Garland | EVP, Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Jan 2022 | 1,530 | 11,112 (0%) | 0% | - | Common Stock | |
Integer Holdings Corp | Jason K. Garland | EVP, Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 79.76 per share. | 21 Jan 2022 | 454 | 10,658 (0%) | 0% | 79.8 | 36,211 | Common Stock |
Integer Holdings Corp | Jason K. Garland | EVP, Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Oct 2021 | 2,490 | 8,539 (0%) | 0% | - | Common Stock | |
Integer Holdings Corp | Jason K. Garland | EVP, Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Oct 2021 | 2,490 | 0 | - | - | Restricted Stock Units | |
Integer Holdings Corp | Jason K. Garland | EVP, Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 92.12 per share. | 02 Oct 2021 | 607 | 7,932 (0%) | 0% | 92.1 | 55,917 | Common Stock |
Integer Holdings Corp | Jason K. Garland | EVP, Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jan 2021 | 4,591 | 4,591 | - | - | Restricted Stock Units | |
Integer Holdings Corp | Jason K. Garland | EVP, Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Dec 2020 | 1,204 | 2,410 | - | - | Restricted Stock Units | |
Integer Holdings Corp | Jason K. Garland | EVP, Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Dec 2020 | 1,204 | 5,656 (0%) | 0% | - | Common Stock | |
Integer Holdings Corp | Jason K. Garland | EVP, Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Dec 2020 | 977 | 978 | - | - | Restricted Stock Units | |
Integer Holdings Corp | Jason K. Garland | EVP, Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Dec 2020 | 977 | 6,339 (0%) | 0% | - | Common Stock | |
Integer Holdings Corp | Jason K. Garland | EVP, Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 81.19 per share. | 31 Dec 2020 | 294 | 5,362 (0%) | 0% | 81.2 | 23,870 | Common Stock |
Integer Holdings Corp | Jason K. Garland | EVP, Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 81.19 per share. | 31 Dec 2020 | 290 | 6,049 (0%) | 0% | 81.2 | 23,545 | Common Stock |
Integer Holdings Corp | Jason K. Garland | EVP, Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Oct 2020 | 2,490 | 2,490 | - | - | Restricted Stock Units | |
Integer Holdings Corp | Jason K. Garland | EVP, Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Oct 2020 | 2,490 | 5,059 (0%) | 0% | - | Common Stock | |
Integer Holdings Corp | Jason K. Garland | EVP, Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 57.76 per share. | 02 Oct 2020 | 607 | 4,452 (0%) | 0% | 57.8 | 35,060 | Common Stock |